SGLT2 in Patients With Type 2 Diabetes Lowers Risk of Gout :

A retrospective, adjusted analysis of people in China with type 2 diabetes significantly linked SGLT2 inhibitor use with a lower risk of gout compared with those receiving a DPP4 inhibitor.

Related Keywords

Hong Kong , , Preprints With The Lancet , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Gout , Sglt2 Inhibitors , Odium Glucose Transporter 2 Inhibitors , Odium Glucose Co Transporter 2 Inhibitors , Sodium Glucose Cotransporter 2 Inhibitors , Diabetes Mellitus , Dpp 4 Inhibitors , Dipeptidyl Peptidase 4 Inhibitors ,